G. Vaughan Hudson

A Prognostic Score for Advanced Hodgkin's Disease

Dirk Hasenclever, Volker Diehl, Jamés O. Armitage et al. · New England Journal of Medicine · 1998 · 1.7K citations · Full text

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan et al. · The Lancet · 1993 · 1K citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +9

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

KM Ardeshna, Peter Smith, AJ Norton et al. · The Lancet · 2003 · 538 citations

Lymphoid Neoplasia, Long-term Effect, Health Policy +4

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Anthony J. Swerdlow, Julie Barber, G. Vaughan Hudson et al. · Journal of Clinical Oncology · 2000 · 475 citations

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study

ME Hill, KA MacLennan, David Cunningham et al. · Blood · 1996 · 311 citations · Full text